ecancermedicalscience

2 months ago | ecancer.org | Poonam Joshi |Rakesh Garg |Uma Shanker Agrawal |Parveen Deswal

Background: Caregivers of children with cancer often experience significant psychological distress exacerbated by financial constraints and role modifications. This study aimed to assess the prevalence of anxiety and depression among caregivers of children receiving cancer treatment and to examine their coping mechanisms. Methods: This cross-sectional study included 124 caregivers of children receiving chemotherapy at a tertiary care facility in Northern India.

Nov 14, 2024 | ecancer.org | Nidhi Gupta |Kislay Dimri |Aanchal Arora |Sudhir Kumar Garg

Background: There is limited data from India on Ewing sarcoma (ES) patients. We analysed the demographic and clinical profile of ES patients, the systemic chemotherapy, local treatment and outcomes in patients with localised, metastatic and recurrent disease. Methods: Data of ES patients reporting from 2010 to 2019 to a tertiary care referral centre in north India was evaluated. A total of 81 patients were retrieved of whom 76 were assessed for treatment and outcomes.

Mar 26, 2024 | ecancer.org | Heba Ayoub |Fifi Mostafa Elsayed |Maha Lotfy Zamzam |Ihab Mohamed Hassanin

Background: The role of cytoreductive local radiotherapy (RT) in metastatic prostate cancer (mPCa) has recently been established. This study aimed to evaluate the biochemical outcome of local RT in mPCa. Methods: This randomised controlled phase III study was conducted at the Clinical Oncology Department, Suez Canal University Hospital. Eligible participants were de-novo or metachronous mPCa patients with Eastern Cooperative Oncology Group performance status of 0–2.

Jan 30, 2024 | ecancer.org | Richard M. Sullivan

Richard Sullivan Institute of Cancer Policy, Centre for Cancer, Society & Public Health, King’s College London, London SW1 9RT, UK Abstract Cancer medicines have become one of the most dominant global medical technologies. They generate huge profits for the biopharmaceutical industry as well as fuel the research and advocacy activities of public funders, patient organisations, clinical and scientific communities and entire federal political ecosystems.

Jul 14, 2023 | ecancer.org | Carmen Garcia |Carmen García |Alvaro Rodriguez |Álvaro Rodriguez |Álvaro Rodríguez

How likely is this article to improve patient care in your region? Is reading this article likely to improve your clinical practice? How likely are you to recommend this article to a colleague?